Active	Status	Sponsor type	Region	Phase	Filter
1 Active 6 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lima, Marcos J de
NCT06180863: Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients	Withdrawn	2		US	oral azacitidine (CC-486), Onureg	Yale University, Bristol-Myers Squibb, National Cancer Institute (NCI)	Acute Myeloid Leukemia	11/28	04/29